| scholarly article | Q13442814 |
| P2093 | author name string | Rebecca C Christofferson | |
| Anu Susan Charles | |||
| P2860 | cites work | Zika virus. I. Isolations and serological specificity | Q22240545 |
| Zika Virus Outbreak on Yap Island, Federated States of Micronesia | Q22250881 | ||
| Outbreak of Exanthematous Illness Associated with Zika, Chikungunya, and Dengue Viruses, Salvador, Brazil | Q22330692 | ||
| Zika Virus Outbreak, Bahia, Brazil | Q22330702 | ||
| Zika virus infection, Cambodia, 2010 | Q22330765 | ||
| Cross-infection enhancement among African flaviviruses by immune mouse ascitic fluids | Q22330830 | ||
| Zika virus infections in Nigeria: virological and seroepidemiological investigations in Oyo State | Q22330859 | ||
| Zika virus. II. Pathogenicity and physical properties | Q22330899 | ||
| A Mouse Model of Zika Virus Pathogenesis | Q24261408 | ||
| Zika virus: History, emergence, biology, and prospects for control | Q24261421 | ||
| Localization and Characterization of Flavivirus Envelope Glycoprotein Cross-Reactive Epitopes | Q24289053 | ||
| Neutralizing antibodies against arthropod-borne viruses in the sera of long-time residents of Malaya and Borneo | Q24471193 | ||
| Arthropod-borne virus antibodies in sera from residents of South-East Asia | Q24471322 | ||
| Serological survey for a arthropod-borne virus infections in the Philippines | Q24471377 | ||
| Infection of human cells by dengue virus is modulated by different cell types and viral strains | Q27469687 | ||
| Dengue Hemorrhagic Fever in Infants: Research Opportunities Ignored | Q27489549 | ||
| Infection enhancement of dengue type 2 virus in the U-937 human monocyte cell line by antibodies to flavivirus cross-reactive determinants | Q33912693 | ||
| Efficacy of a tetravalent dengue vaccine in children in Latin America. | Q34446032 | ||
| Maternal antibody and viral factors in the pathogenesis of dengue virus in infants | Q35097469 | ||
| Flavivirus-induced antibody cross-reactivity | Q35961340 | ||
| Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection | Q38087545 | ||
| The many projected futures of dengue | Q38366682 | ||
| Identification of Distinct Antigenic Determinants on Dengue-2 Virus Using Monoclonal Antibodies | Q40845088 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| Zika virus | Q202864 | ||
| monoclonal antibody | Q422248 | ||
| Dengue virus | Q476209 | ||
| Zika virus infection | Q27043680 | ||
| P5008 | on focus list of Wikimedia project | WikiProject Zika Corpus | Q54439832 |
| P577 | publication date | 2016-07-05 | |
| P1433 | published in | PLOS Currents | Q7119653 |
| P1476 | title | Utility of a Dengue-Derived Monoclonal Antibody to Enhance Zika Infection In Vitro | |
| P478 | volume | 8 |
| Q58769644 | A conceptual model for optimizing vaccine coverage to reduce vector-borne infections in the presence of antibody-dependent enhancement |
| Q38156667 | Advances in Developing Therapies to Combat Zika Virus: Current Knowledge and Future Perspectives |
| Q62485190 | Antigenic cross-reactivity between Zika and dengue viruses: is it time to develop a universal vaccine? |
| Q55277816 | Biochemistry and Molecular Biology of Flaviviruses. |
| Q30145645 | Characterization of Zika virus binding and enhancement potential of a large panel of flavivirus murine monoclonal antibodies |
| Q56343523 | Dengue immune sera enhance Zika virus infection in human peripheral blood monocytes through Fc gamma receptors |
| Q45324929 | Dengue virus-reactive CD8+ T cells mediate cross-protection against subsequent Zika virus challenge |
| Q27928012 | Implication of vaccination against dengue for Zika outbreak |
| Q59245659 | Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice |
| Q54217627 | Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection. |
| Q40052932 | Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice |
| Q30235612 | Prospects for a Zika Virus Vaccine |
| Q57466493 | Role of Host Cell Secretory Machinery in Zika Virus Life Cycle |
| Q89799882 | The effects of Japanese encephalitis virus antibodies on Zika virus infection |
| Q63248438 | The possible role of cross-reactive dengue virus antibodies in Zika virus pathogenesis |
| Q65054977 | Using Macaques to Address Critical Questions in Zika Virus Research. |
| Q29571224 | Vaccination strategies against Zika virus |
| Q28733400 | Zika Virus Pathogenesis and Tissue Tropism |
| Q29587262 | Zika Virus Persistence in the Central Nervous System and Lymph Nodes of Rhesus Monkeys |
| Q63246295 | Zika Virus-Specific IgY Results Are Therapeutic Following a Lethal Zika Virus Challenge without Inducing Antibody-Dependent Enhancement |
| Q60919470 | Zika Virus: Origins, Pathological Action, and Treatment Strategies |
| Q41918368 | Zika virus infection confers protection against West Nile virus challenge in mice |
Search more.